Role and expression of FRS2 and FRS3 in prostate cancer

<p>Abstract</p> <p>Background</p> <p>FGF receptor substrates (FRS2 and FRS3) are key adaptor proteins that mediate FGF-FGFR signalling in benign as well as malignant tissue. Here we investigated FRS2 and FRS3 as a means of disrupting global FGF signalling in prostate ca...

Full description

Bibliographic Details
Main Authors: Valencia Tania, Joseph Ajay, Kachroo Naveen, Darby Steve, Meakin Susan, Gnanapragasam Vincent J
Format: Article
Language:English
Published: BMC 2011-11-01
Series:BMC Cancer
Subjects:
Online Access:http://www.biomedcentral.com/1471-2407/11/484